{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:50:52Z","timestamp":1787320252886,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15567-4","type":"journal-article","created":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T17:01:36Z","timestamp":1720371696000},"page":"6504-6513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review"],"prefix":"10.1245","volume":"31","author":[{"given":"Elliott J.","family":"Yee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A.","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Moris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Torphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Mungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Del Chiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,7]]},"reference":[{"issue":"4","key":"15567_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","volume":"224","author":"A Nakeeb","year":"1996","unstructured":"Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463\u201373. https:\/\/doi.org\/10.1097\/00000658-199610000-00005.","journal-title":"Ann Surg."},{"issue":"17","key":"15567_CR2","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery MA, Ptashkin R, Jordan E, et al. Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention. Clin Cancer Res. 2018;24(17):4154\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0078.","journal-title":"Clin Cancer Res."},{"issue":"3","key":"15567_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","volume":"181","author":"JH Lim","year":"2003","unstructured":"Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol. 2003;181(3):819\u201327. https:\/\/doi.org\/10.2214\/ajr.181.3.1810819.","journal-title":"AJR Am J Roentgenol."},{"issue":"11","key":"15567_CR4","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.ejso.2019.06.032","volume":"45","author":"AM Schreuder","year":"2019","unstructured":"Schreuder AM, Engelsman AF, van Roessel S, et al. Treatment of mid-bile duct carcinoma: Local resection or pancreatoduodenectomy? Eur J Surg Oncol. 2019;45(11):2180\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.032.","journal-title":"Eur J Surg Oncol."},{"key":"15567_CR5","doi-asserted-by":"publisher","unstructured":"Gkountakos A, Martelli FM, Silvestris N, et al. Extrahepatic distal cholangiocarcinoma vs. pancreatic ductal adenocarcinoma: histology and molecular profiling for differential diagnosis and treatment. Cancers (Basel). 2023;15(5). https:\/\/doi.org\/10.3390\/cancers15051454","DOI":"10.3390\/cancers15051454"},{"issue":"2","key":"15567_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.hbpd.2020.01.002","volume":"19","author":"M Akita","year":"2020","unstructured":"Akita M, Ajiki T, Ueno K, et al. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2020;19(2):147\u201352. https:\/\/doi.org\/10.1016\/j.hbpd.2020.01.002.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"47","key":"15567_CR7","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.3748\/wjg.15.5966","volume":"15","author":"HG Lee","year":"2009","unstructured":"Lee HG, Lee SH, Yoo DD, et al. Carcinoma of the middle bile duct: is bile duct segmental resection appropriate? World J Gastroenterol. 2009;15(47):5966\u201371. https:\/\/doi.org\/10.3748\/wjg.15.5966.","journal-title":"World J Gastroenterol."},{"issue":"9","key":"15567_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"7","key":"15567_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/0284186x.2019.1590634","volume":"58","author":"M Strijker","year":"2019","unstructured":"Strijker M, Belkouz A, van der Geest LG, et al. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol. 2019;58(7):1048\u201355. https:\/\/doi.org\/10.1080\/0284186x.2019.1590634.","journal-title":"Acta Oncol."},{"issue":"5","key":"15567_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261\u201380. https:\/\/doi.org\/10.1038\/nrgastro.2016.51.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"Suppl 1","key":"15567_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331. https:\/\/doi.org\/10.1111\/liv.14095.","journal-title":"Liver Int."},{"issue":"1","key":"15567_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019;71(1):104\u201314. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.013.","journal-title":"J Hepatol."},{"issue":"1","key":"15567_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12876-016-0527-z","volume":"16","author":"KJ Yao","year":"2016","unstructured":"Yao KJ, Jabbour S, Parekh N, Lin Y, Moss RA. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. BMC Gastroenterol. 2016;16(1):117. https:\/\/doi.org\/10.1186\/s12876-016-0527-z.","journal-title":"BMC Gastroenterol."},{"issue":"Suppl 1","key":"15567_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98\u2013107. https:\/\/doi.org\/10.1111\/liv.14086.","journal-title":"Liver Int."},{"issue":"4","key":"15567_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/cncr.21842","volume":"108","author":"KE Volmar","year":"2006","unstructured":"Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods. Cancer. 2006;108(4):231\u20138. https:\/\/doi.org\/10.1002\/cncr.21842.","journal-title":"Cancer."},{"key":"15567_CR16","unstructured":"Network NCC. Biliary Tract Cancers (version 2.2023). 2023;"},{"key":"15567_CR17","doi-asserted-by":"publisher","unstructured":"Orzan RI, Pojoga C, Agoston R, Seicean R, Seicean A. Endoscopic ultrasound in the diagnosis of extrahepatic cholangiocarcinoma: what do we know in 2023? Diagnostics (Basel). 2023;13(6)https:\/\/doi.org\/10.3390\/diagnostics13061023","DOI":"10.3390\/diagnostics13061023"},{"issue":"26","key":"15567_CR18","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.3748\/wjg.14.4131","volume":"14","author":"A Weber","year":"2008","unstructured":"Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14(26):4131\u20136. https:\/\/doi.org\/10.3748\/wjg.14.4131.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"15567_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/13651820801992666","volume":"10","author":"Y Nimura","year":"2008","unstructured":"Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford). 2008;10(2):130\u20133. https:\/\/doi.org\/10.1080\/13651820801992666.","journal-title":"HPB (Oxford)."},{"issue":"8","key":"15567_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/bjs.1800810839","volume":"81","author":"EC Lai","year":"1994","unstructured":"Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg. 1994;81(8):1195\u20138. https:\/\/doi.org\/10.1002\/bjs.1800810839.","journal-title":"Br J Surg."},{"issue":"8304","key":"15567_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(82)90866-2","volume":"2","author":"AR Hatfield","year":"1982","unstructured":"Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982;2(8304):896\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(82)90866-2.","journal-title":"Lancet."},{"issue":"2","key":"15567_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/den.12394","volume":"27","author":"P Saxena","year":"2015","unstructured":"Saxena P, Kumbhari V, Zein ME, Khashab MA. Preoperative biliary drainage. Dig Endosc. 2015;27(2):265\u201377. https:\/\/doi.org\/10.1111\/den.12394.","journal-title":"Dig Endosc."},{"issue":"2","key":"15567_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/bjs.8950","volume":"100","author":"O Farges","year":"2013","unstructured":"Farges O, Regimbeau JM, Fuks D, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100(2):274\u201383. https:\/\/doi.org\/10.1002\/bjs.8950.","journal-title":"Br J Surg."},{"issue":"1","key":"15567_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.SLA.0000074984.83031.02","volume":"238","author":"S Kawasaki","year":"2003","unstructured":"Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238(1):84\u201392. https:\/\/doi.org\/10.1097\/01.SLA.0000074984.83031.02.","journal-title":"Ann Surg."},{"issue":"1","key":"15567_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","volume":"241","author":"JY Jang","year":"2005","unstructured":"Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg. 2005;241(1):77\u201384. https:\/\/doi.org\/10.1097\/01.sla.0000150166.94732.88.","journal-title":"Ann Surg."},{"issue":"2","key":"15567_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5306\/wjco.v2.i2.94","volume":"2","author":"N Akamatsu","year":"2011","unstructured":"Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol. 2011;2(2):94\u2013107. https:\/\/doi.org\/10.5306\/wjco.v2.i2.94.","journal-title":"World J Clin Oncol."},{"issue":"14","key":"15567_CR27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med."},{"issue":"9","key":"15567_CR28","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.3390\/curroncol29090524","volume":"29","author":"L Gorji","year":"2022","unstructured":"Gorji L, Beal EW. Surgical treatment of distal Cholangiocarcinoma. Curr Oncol. 2022;29(9):6674\u201387. https:\/\/doi.org\/10.3390\/curroncol29090524.","journal-title":"Curr Oncol."},{"key":"15567_CR29","doi-asserted-by":"publisher","unstructured":"Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9. https:\/\/doi.org\/10.3322\/caac.21388","DOI":"10.3322\/caac.21388"},{"issue":"6","key":"15567_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jhbp.724","volume":"27","author":"H Hayashi","year":"2020","unstructured":"Hayashi H, Jang JY, Kim KS, et al. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi-center collaborating study of Japan and Korea. J Hepatobiliary Pancreat Sci. 2020;27(6):289\u201398. https:\/\/doi.org\/10.1002\/jhbp.724.","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"4","key":"15567_CR31","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1245\/s10434-020-09157-3","volume":"28","author":"K Jikei","year":"2021","unstructured":"Jikei K, Ebata T, Mizuno T, et al. Oncologic reappraisal of bile duct resection for middle-third Cholangiocarcinoma. Ann Surg Oncol. 2021;28(4):1990\u20139. https:\/\/doi.org\/10.1245\/s10434-020-09157-3.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"15567_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SLA.0b013e31826029ca","volume":"256","author":"T Ebata","year":"2012","unstructured":"Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256(2):297\u2013305. https:\/\/doi.org\/10.1097\/SLA.0b013e31826029ca.","journal-title":"Ann Surg."},{"issue":"2","key":"15567_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13304-021-00981-0","volume":"73","author":"T Guilbaud","year":"2021","unstructured":"Guilbaud T, Girard E, Lemoine C, et al. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis? Updates Surg. 2021;73(2):439\u201350. https:\/\/doi.org\/10.1007\/s13304-021-00981-0.","journal-title":"Updates Surg."},{"issue":"1","key":"15567_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00000658-199901000-00010","volume":"229","author":"M Kayahara","year":"1999","unstructured":"Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Tajima H, Miwa K. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg. 1999;229(1):76\u201383. https:\/\/doi.org\/10.1097\/00000658-199901000-00010.","journal-title":"Ann Surg."},{"issue":"45","key":"15567_CR35","first-page":"625","volume":"49","author":"Y Okazaki","year":"2002","unstructured":"Okazaki Y, Horimi T, Kotaka M, Morita S, Takasaki M. Study of the intrahepatic surgical margin of hilar bile duct carcinoma. Hepatogastroenterology. 2002;49(45):625\u20137.","journal-title":"Hepatogastroenterology."},{"issue":"2","key":"15567_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13651820510028873","volume":"7","author":"K Yamaguchi","year":"2005","unstructured":"Yamaguchi K, Shirahane K, Nakamura M, et al. Frozen section and permanent diagnoses of the bile duct margin in gallbladder and bile duct cancer. HPB (Oxford). 2005;7(2):135\u20138. https:\/\/doi.org\/10.1080\/13651820510028873.","journal-title":"HPB (Oxford)."},{"issue":"8","key":"15567_CR37","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1245\/s10434-008-0003-2","volume":"15","author":"I Endo","year":"2008","unstructured":"Endo I, House MG, Klimstra DS, et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15(8):2104\u201312. https:\/\/doi.org\/10.1245\/s10434-008-0003-2.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"15567_CR38","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1245\/s10434-006-9260-0","volume":"14","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol. 2007;14(3):1212\u20139. https:\/\/doi.org\/10.1245\/s10434-006-9260-0.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"15567_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1067\/msy.2001.114555","volume":"129","author":"R Sasaki","year":"2001","unstructured":"Sasaki R, Takahashi M, Funato O, et al. Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery. 2001;129(6):677\u201383. https:\/\/doi.org\/10.1067\/msy.2001.114555.","journal-title":"Surgery."},{"issue":"2","key":"15567_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11605-006-0018-6","volume":"11","author":"RE Schwarz","year":"2007","unstructured":"Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on US population data. J Gastrointest Surg. 2007;11(2):158\u201365. https:\/\/doi.org\/10.1007\/s11605-006-0018-6.","journal-title":"J Gastrointest Surg."},{"key":"15567_CR41","doi-asserted-by":"publisher","unstructured":"Kang JS, Higuchi R, He J, et al. Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition). J Hepatobiliary Pancreat Sci. 2020;27(2):75-83. https:\/\/doi.org\/10.1002\/jhbp.690","DOI":"10.1002\/jhbp.690"},{"issue":"9","key":"15567_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3748\/wjg.v24.i9.1022","volume":"24","author":"HP Lin","year":"2018","unstructured":"Lin HP, Li SW, Liu Y, Zhou SJ. Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas. World J Gastroenterol. 2018;24(9):1022\u201334. https:\/\/doi.org\/10.3748\/wjg.v24.i9.1022.","journal-title":"World J Gastroenterol."},{"key":"15567_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2023.06.012","author":"AM Fleming","year":"2023","unstructured":"Fleming AM, Phillips AL, Hendrick LE, et al. Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies. HPB (Oxford). 2023. https:\/\/doi.org\/10.1016\/j.hpb.2023.06.012.","journal-title":"HPB (Oxford)"},{"issue":"2","key":"15567_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.asjsur.2015.07.002","volume":"40","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Liu S, Wu L, Wan T. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg. 2017;40(2):129\u201338. https:\/\/doi.org\/10.1016\/j.asjsur.2015.07.002.","journal-title":"Asian J Surg."},{"issue":"3","key":"15567_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000513563","volume":"38","author":"YH Park","year":"2021","unstructured":"Park YH, Seo SH, An MS, Baik H, Lee CH. Prognostic impact of resection margin length in patients undergoing resection for mid-common bile duct cancer: a single-center experience. Dig Surg. 2021;38(3):212\u201321. https:\/\/doi.org\/10.1159\/000513563.","journal-title":"Dig Surg."},{"issue":"1","key":"15567_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000118025","volume":"25","author":"S Hwang","year":"2008","unstructured":"Hwang S, Lee SG, Kim KH, et al. Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer. Dig Surg. 2008;25(1):74\u20139. https:\/\/doi.org\/10.1159\/000118025.","journal-title":"Dig Surg."},{"issue":"6","key":"15567_CR47","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11605-014-2490-8","volume":"18","author":"T Noji","year":"2014","unstructured":"Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Tanaka E, Hirano S. Surgical outcome of hilar plate resection: extended hilar bile duct resection without hepatectomy. J Gastrointest Surg. 2014;18(6):1131\u20137. https:\/\/doi.org\/10.1007\/s11605-014-2490-8.","journal-title":"J Gastrointest Surg."},{"issue":"5","key":"15567_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X.","journal-title":"Lancet Oncol."},{"issue":"10372","key":"15567_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401(10372):195\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(22)02038-4.","journal-title":"Lancet."},{"issue":"8","key":"15567_CR50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.18.00050","volume":"37","author":"J Edeline","year":"2019","unstructured":"Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A randomized phase III study. J Clin Oncol. 2019;37(8):658\u201367. https:\/\/doi.org\/10.1200\/JCO.18.00050.","journal-title":"J Clin Oncol."},{"issue":"3","key":"15567_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/bjs.10776","volume":"105","author":"T Ebata","year":"2018","unstructured":"Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg. 2018;105(3):192\u2013202. https:\/\/doi.org\/10.1002\/bjs.10776.","journal-title":"Br J Surg."},{"issue":"12","key":"15567_CR52","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.18.02178","volume":"37","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37(12):1015\u201327. https:\/\/doi.org\/10.1200\/JCO.18.02178.","journal-title":"J Clin Oncol."},{"issue":"6","key":"15567_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0002-9610(97)00203-1","volume":"174","author":"KM McMasters","year":"1997","unstructured":"McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg. 1997;174(6):605\u20138. https:\/\/doi.org\/10.1016\/s0002-9610(97)00203-1.","journal-title":"Am J Surg."},{"issue":"1","key":"15567_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijrobp.2008.07.008","volume":"73","author":"JW Nelson","year":"2009","unstructured":"Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009;73(1):148\u201353. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.07.008.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"15567_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.amjsurg.2018.08.024","volume":"218","author":"JM Cloyd","year":"2019","unstructured":"Cloyd JM, Prakash L, Vauthey JN, et al. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. 2019;218(1):145\u201350. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.08.024.","journal-title":"Am J Surg."},{"issue":"1","key":"15567_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijrobp.2006.11.048","volume":"68","author":"MA Hughes","year":"2007","unstructured":"Hughes MA, Frassica DA, Yeo CJ, et al. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007;68(1):178\u201382. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.11.048.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"15567_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/1471-2407-9-345","volume":"9","author":"KH Lim","year":"2009","unstructured":"Lim KH, Oh DY, Chie EK, et al. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer? a non-randomized, single center study. BMC Cancer. 2009;9:345. https:\/\/doi.org\/10.1186\/1471-2407-9-345.","journal-title":"BMC Cancer."},{"issue":"1","key":"15567_CR58","doi-asserted-by":"publisher","first-page":"12348","DOI":"10.1038\/s41598-020-69366-4","volume":"10","author":"S Ahn","year":"2020","unstructured":"Ahn S, Lee JC, Shin DW, Kim J, Hwang JH. High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer. Sci Rep. 2020;10(1):12348. https:\/\/doi.org\/10.1038\/s41598-020-69366-4.","journal-title":"Sci Rep."},{"key":"15567_CR59","unstructured":"Oh DY HA, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. N Engl J Med Evidence. 2022;1-11(Epub ahead of print.)"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15567-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:25:49Z","timestamp":1726741549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15567-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15567"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15567-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,7]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Del Chiaro has received an industry grant (Haemonetics, Inc.) to conduct a multicenter study. Dr. Del Chiaro is the principal investigator of an international multicenter study sponsored by Boston Scientific. Dr. Schulick is a coinventor of a patent licensed to DynamiCure (managed by the University of Colorado) outside the submitted work. No other disclosures were reported from the other authors. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}